miRNA profiling of circulating EpCAM⁺ extracellular vesicles: promising biomarkers of colorectal cancer

References

• Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, etal. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015; 136: E359–86.
   PubMed Web of Science ®Google Scholar
• Etzioni R, Urban N, Ramsey S, McIntosh M, Schwartz S, Reid B, etal. The case for early detection. Nat Rev Cancer. 2003; 3: 243–52.
   PubMed Web of Science ®Google Scholar
• Levin TR, Jamieson L, Burley DA, Reyes J, Oehrli M, Caldwell C. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev. 2011; 33: 101–10.
   PubMed Web of Science ®Google Scholar
• Kuipers EJ, Rosch T, Bretthauer M. Colorectal cancer screening – optimizing current strategies and new directions. Nat Rev Clin Oncol. 2013; 10: 130–42.
   PubMed Web of Science ®Google Scholar
• Nielsen HJ, Jakobsen KV, Christensen IJ, Brunner N. Danish Study Group on Early Detection of Colorectal Cancer. Screening for colorectal cancer: possible improvements by risk assessment evaluation?. Scand J Gastroenterol. 2011; 46: 1283–94.
   PubMed Web of Science ®Google Scholar
• Sanford KW, McPherson RA. Fecal occult blood testing. Clin Lab Med. 2009; 29: 523–41.
   PubMed Web of Science ®Google Scholar
• Clancy C, Joyce MR, Kerin MJ. The use of circulating microRNAs as diagnostic biomarkers in colorectal cancer. Cancer Biomark. 2015; 15: 103–13.
   PubMed Web of Science ®Google Scholar
• Du M, Liu S, Gu D, Wang Q, Zhu L, Kang M, etal. Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients. Carcinogenesis. 2014; 35: 2723–30.
   PubMed Web of Science ®Google Scholar
• Rokkas T, Kothonas F, Rokka A, Koukoulis G, Symvoulakis E. The role of circulating microRNAs as novel biomarkers in diagnosing colorectal cancer: a meta-analysis. Eur J Gastroenterol Hepatol. 2015; 27: 819–25.
   Web of Science ®Google Scholar
• Pritchard CC, Kroh E, Wood B, Arroyo JD, Dougherty KJ, Miyaji MM, etal. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res. 2012; 5: 492–7.
   PubMed Web of Science ®Google Scholar
• Cheng HH, Yi HS, Kim Y, Kroh EM, Chien JW, Eaton KD, etal. Plasma processing conditions substantially influence circulating microRNA biomarker levels. PLoS One. 2013; 8: e64795.
   PubMed Web of Science ®Google Scholar
• MacLellan SA, MacAulay C, Lam S, Garnis C. Pre-profiling factors influencing serum microRNA levels. BMC Clin Pathol. 2014; 14: 27.
   PubMedGoogle Scholar
• Yamada A, Cox MA, Gaffney KA, Moreland A, Boland CR, Goel A. Technical factors involved in the measurement of circulating microRNA biomarkers for the detection of colorectal neoplasia. PLoS One. 2014; 9: e112481.
   PubMed Web of Science ®Google Scholar
• Zanutto S, Pizzamiglio S, Ghilotti M, Bertan C, Ravagnani F, Perrone F, etal. Circulating miR-378 in plasma: a reliable, haemolysis-independent biomarker for colorectal cancer. Br J Cancer. 2014; 110: 1001–7.
   PubMed Web of Science ®Google Scholar
• Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18:997–1006..
   Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, etal. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008; 105: 10513–8.
   PubMed Web of Science ®Google Scholar
• Li L, Zhu D, Huang L, Zhang J, Bian Z, Chen X, etal. Argonaute 2 complexes selectively protect the circulating microRNAs in cell-secreted microvesicles. PLoS One. 2012; 7: e46957.
   PubMed Web of Science ®Google Scholar
• Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, etal. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A. 2011; 108: 5003–8.
   PubMed Web of Science ®Google Scholar
• Koberle V, Pleli T, Schmithals C, Augusto Alonso E, Haupenthal J, Bonig H, etal. Differential stability of cell-free circulating microRNAs: implications for their utilization as biomarkers. PLoS One. 2013; 8: e75184.
   PubMed Web of Science ®Google Scholar
• Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol. 2011; 13: 423–33.
   PubMed Web of Science ®Google Scholar
• Yanez-Mo M, Siljander PR, Andreu Z, Zavec AB, Borras FE, Buzas EI, etal. Biological properties of EVs and their physiological functions. J Extracell Vesicles. 2015; 4: 27066, doi: http://dx.doi.org/10.3402/jev.v4.27066.
   Google Scholar
• Rabinowits G, Gercel-Taylor C, Day JM, Taylor DD, Kloecker GH. Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer. 2009; 10: 42–6.
   PubMed Web of Science ®Google Scholar
• Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol. 2008; 110: 13–21.
   PubMed Web of Science ®Google Scholar
• Lazaro-Ibanez E, Sanz-Garcia A, Visakorpi T, Escobedo-Lucea C, Siljander P, Ayuso-Sacido A, etal. Different gDNA content in the subpopulations of prostate cancer extracellular vesicles: apoptotic bodies, microvesicles, and exosomes. Prostate. 2014; 74: 1379–90.
   PubMed Web of Science ®Google Scholar
• Yoshioka Y, Kosaka N, Konishi Y, Ohta H, Okamoto H, Sonoda H, etal. Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen. Nat Commun. 2014; 5: 3591.
   PubMed Web of Science ®Google Scholar
• Jeppesen DK, Nawrocki A, Jensen SG, Thorsen K, Whitehead B, Howard KA, etal. Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors. Proteomics. 2014; 14: 699–712.
   PubMed Web of Science ®Google Scholar
• Mitchell JP, Court J, Mason MD, Tabi Z, Clayton A. Increased exosome production from tumour cell cultures using the Integra CELLine Culture System. J Immunol Methods. 2008; 335: 98–105.
   PubMed Web of Science ®Google Scholar
• Fredriksson S, Gullberg M, Jarvius J, Olsson C, Pietras K, Gustafsdottir SM, etal. Protein detection using proximity-dependent DNA ligation assays. Nat Biotechnol. 2002; 20: 473–7.
   PubMed Web of Science ®Google Scholar
• Lundberg M, Thorsen SB, Assarsson E, Villablanca A, Tran B, Gee N, etal. Multiplexed homogeneous proximity ligation assays for high-throughput protein biomarker research in serological material. Mol Cell Proteomics. 2011; 10: M110 004978.
   PubMed Web of Science ®Google Scholar
• Jensen SG, Lamy P, Rasmussen MH, Ostenfeld MS, Dyrskjot L, Orntoft TF, etal. Evaluation of two commercial global miRNA expression profiling platforms for detection of less abundant miRNAs. BMC Genomics. 2011; 12: 435.
   PubMed Web of Science ®Google Scholar
• Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, etal. TM4: a free, open-source system for microarray data management and analysis. Biotechniques. 2003; 34: 374–8.
   PubMed Web of Science ®Google Scholar
• de Hoon MJ, Imoto S, Nolan J, Miyano S. Open source clustering software. Bioinformatics. 2004; 20: 1453–4.
   PubMed Web of Science ®Google Scholar
• Coffey RJ Jr , Shipley GD, Moses HL. Production of transforming growth factors by human colon cancer lines. Cancer Res. 1986; 46: 1164–9.
   PubMed Web of Science ®Google Scholar
• Christensen LL, Holm A, Rantala J, Kallioniemi O, Rasmussen MH, Ostenfeld MS, etal. Functional screening identifies miRNAs influencing apoptosis and proliferation in colorectal cancer. PLoS One. 2014; 9: E96767.
   PubMed Web of Science ®Google Scholar
• Jahid S, Sun J, Edwards RA, Dizon D, Panarelli NC, Milsom JW, etal. miR-23a promotes the transition from indolent to invasive colorectal cancer. Cancer Discov. 2012; 2: 540–53.
   Web of Science ®Google Scholar
• Slattery ML, Wolff E, Hoffman MD, Pellatt DF, Milash B, Wolff RK. MicroRNAs and colon and rectal cancer: differential expression by tumor location and subtype. Genes Chromosomes Cancer. 2011; 50: 196–206.
   Web of Science ®Google Scholar
• Monzo M, Navarro A, Bandres E, Artells R, Moreno I, Gel B, etal. Overlapping expression of microRNAs in human embryonic colon and colorectal cancer. Cell Res. 2008; 18: 823–33.
   PubMed Web of Science ®Google Scholar
• Liu S, Sun X, Wang M, Hou Y, Zhan Y, Jiang Y, etal. A microRNA 221- and 222-mediated feedback loop maintains constitutive activation of NFkappaB and STAT3 in colorectal cancer cells. Gastroenterology. 2014; 147: 847–59. e11.
   PubMed Web of Science ®Google Scholar
• Ostenfeld MS, Jeppesen DK, Laurberg JR, Boysen AT, Bramsen JB, Primdal-Bengtson B, etal. Cellular disposal of miR23b by RAB27-dependent exosome release is linked to acquisition of metastatic properties. Cancer Res. 2014; 74: 5758–71.
   PubMed Web of Science ®Google Scholar
• Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, etal. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med. 2012; 18: 883–91.
   PubMed Web of Science ®Google Scholar
• Zhou X, Xu X, Wang J, Lin J, Chen W. Identifying miRNA/mRNA negative regulation pairs in colorectal cancer. Sci Rep. 2015; 5: 12995.
   Web of Science ®Google Scholar
• Ogata-Kawata H, Izumiya M, Kurioka D, Honma Y, Yamada Y, Furuta K, etal. Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS One. 2014; 9: e92921.
   PubMed Web of Science ®Google Scholar
• Yong FL, Law CW, Wang CW. Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer. BMC Cancer. 2013; 13: 280.
   PubMed Web of Science ®Google Scholar
• Ho GY, Jung HJ, Schoen RE, Wang T, Lin J, Williams Z, etal. Differential expression of circulating microRNAs according to severity of colorectal neoplasia. Transl Res. 2015; 166: 225–32.
   Web of Science ®Google Scholar
• Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, etal. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut. 2009; 58: 1375–81.
   PubMed Web of Science ®Google Scholar
• Kent OA, McCall MN, Cornish TC, Halushka MK. Lessons from miR-143/145: the importance of cell-type localization of miRNAs. Nucleic Acids Res. 2014; 42: 7528–38.
   PubMed Web of Science ®Google Scholar
• Nielsen BS, Jorgensen S, Fog JU, Sokilde R, Christensen IJ, Hansen U, etal. High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients. Clin Exp Metastasis. 2011; 28: 27–38.
   PubMed Web of Science ®Google Scholar
• Toiyama Y, Tanaka K, Inoue Y, Mohri Y, Kusunoki M. Circulating cell-free microRNAs as biomarkers for colorectal cancer. Surg Today. 2016; 46: 13–24.
   Web of Science ®Google Scholar
• El-Khoury V, Pierson S, Kaoma T, Bernardin F, Berchem G. Assessing cellular and circulating miRNA recovery: the impact of the RNA isolation method and the quantity of input material. Sci Rep. 2016; 6: 19529.
   PubMed Web of Science ®Google Scholar